CBS 2019
CBSMD教育中心
中 文

ASCVD Prevention

Abstract

Recommended Article

Glycemic Index, Glycemic Load, and Cardiovascular Disease and Mortality Adenosine and adenosine receptor-mediated action in coronary microcirculation High-Risk Coronary Plaque Regression After Intensive Lifestyle Intervention in Nonobstructive Coronary Disease: A Randomized Study Cardiovascular risk prediction in type 2 diabetes: a comparison of 22 risk scores in primary care settings Plasma Ionized Calcium and Risk of Cardiovascular Disease: 106 774 Individuals from the Copenhagen General Population Study The Science Underlying COVID-19: Implications for the Cardiovascular System Membrane type 1 matrix metalloproteinase promotes LDL receptor shedding and accelerates the development of atherosclerosis Cardiovascular Considerations in Caring for Pregnant Patients: A Scientific Statement From the American Heart Association

Original Research2021 Mar 25;cvab100.

JOURNAL:Cardiovasc Res. Article Link

Treatment and prevention of lipoprotein(a)-mediated cardiovascular disease: the emerging potential of RNA interference therapeutics

DI Swerdlow, DA Rider, A Yavari et al. Keywords: lipoprotein(a)-mediated cardiovascular disease; treatment option; RNA interference therapeutics

Full Text PDF